AnnexMedAnnexMedAnnexMed
Corporate Office
USA
299 S. Main Street
Suite 1300
Salt Lake City, UT 84111
Chennai - Tower I
CeeDeeYes Tyche Towers,
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
Chennai - Tower II
4th Floor, IIFL TOWERS
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram
No 9, Viswalingam Layout
Villupuram,
Tamil Nadu – 605602

Oncology Medical Billing Services

Maximize Your Oncology Practice Revenue with Specialized RCM Solutions

End-to-end neurology RCM built for the complexity of EEG, EMG, nerve conduction studies, time-based billing, and multi-test workflows

96%+

Clean Claim Rate

25–35%

Revenue Increase

82-90%

Denial Overturn

30–40%

A/R Days Reduction

3–4 Wks

Implementation

From chemotherapy suite to radiation vault — multi-layer oncology billing that captures every component

Oncology billing is not merely complex — it is the most documentation-intensive, drug-driven, and compliance-critical revenue cycle in all of healthcare. A single oncology encounter routinely generates multiple high-value claims spanning several billing categories simultaneously: chemotherapy administration coding, buy-and-bill drug billing with J-code precision, radiation therapy technical and professional component splits, prior authorization for high-cost biologics and targeted therapies, supportive care services, and ongoing care coordination. Each category carries distinct CPT and HCPCS codes, wastage documentation requirements, payer authorization thresholds, and NCCI bundling rules. A coding gap in any category means systematic revenue loss multiplied across every treatment encounter.

AnnexMed delivers comprehensive RCM for all oncology provider types: medical oncologists, hematology-oncologists, radiation oncologists, gynecologic oncologists, surgical oncologists, and hospital-based cancer centers. Our certified coders understand the complete oncology billing landscape: chemotherapy administration (96401–96549), infusion hierarchy with initial and sequential sequencing, J-code drug billing with unit calculation and wastage documentation, radiation therapy planning and delivery (77261–77432), immunotherapy and biologic billing with buy-and-bill drug cost recovery, prior authorization for checkpoint inhibitors and targeted agents, clinical trial billing segregation, OCM care coordination services, port access billing (96523), and ICD-10 oncology staging precision across all malignancy categories. We manage the complete revenue cycle from eligibility verification through payment reconciliation — protecting your revenue while your oncologists focus on patient care.

Aboutus-Inner-1

Trusted by 100+ healthcare providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II

soc

Why oncology billing is the most complex in medicine?

Oncology reimbursement carries unique billing risks across drug billing, infusion administration, radiation therapy, and compliance requirements. Small errors in this high-volume, high-cost specialty multiply quickly — a missed J-code unit on a biologic drug, an incorrect infusion sequence across a month of chemotherapy encounters, or a documentation gap on drug wastage translates directly into five- and six-figure revenue losses.

Buy-and-Bill Drug Complexity

High-cost chemotherapy and biologic drugs require precise inventory tracking, J-code selection, unit calculation based on administered dose, ASP pricing compliance, and wastage documentation with JW/JZ modifier billing. Errors in any element create systematic underpayment on every drug encounter.

Chemotherapy Administration Hierarchy

Infusion billing requires correct sequencing of initial (96413), additional hours (96415), push injections (96409), and concurrent drug infusions (96417) based on the exact order of drug administration documented in the infusion flowsheet. Sequencing errors trigger automatic bundling denials.

Same-Day E&M and Chemotherapy Denials

Oncology visits frequently include both an evaluation and management service and a chemotherapy infusion. Billing both requires clear documentation of a separately identifiable E&M service and correct modifier 25 application. Without satisfying payer reviewers, the E&M is denied permanently.

Radiation Therapy Component Billing

Radiation billing spans simulation, treatment planning, dosimetry, and delivery (77261–77432) — a multi-step process requiring correct TC/26 splits between the radiation oncologist and physicist. A single component billed incorrectly cascades through the entire treatment course reimbursement.

NCCI Bundling Rules for Oncology

Oncology carries one of the highest concentrations of NCCI bundling edits in medicine. Infusion codes bundled with E&M, supportive care codes bundled with chemotherapy administration, and same-day port access require expert modifier application and documentation to override edits and capture legitimate revenue.

Prior Authorization for High-Cost Treatments

Chemotherapy regimens, targeted therapies, checkpoint inhibitors, CAR-T therapy, and radiation treatments all require prior authorization with detailed clinical justification. Authorization failures on high-cost services already administered create complex appeals that consume significant staff time.

Immunotherapy & Biologic Billing

Checkpoint inhibitors (pembrolizumab, nivolumab) and REMS-required biologics demand payer-specific prior authorization, precise J-code billing, and buy-and-bill drug cost recovery managed with ASP pricing compliance. Practices under-recovering drug costs are sustaining the largest financial losses in oncology.

Clinical Trial Billing Segregation

Routine care costs billable to insurance must be segregated from trial-covered services across every clinical trial encounter. Payer-specific clinical trial billing policies and IRB compliance add documentation complexity. Misattribution creates both revenue loss and compliance exposure simultaneously.

Core RCM services

The following nine core services form the foundation of AnnexMed’s standard RCM offering for every oncology practice. Each service is customized to the multi-drug, multi-modality, and high-value billing workflows that define cancer care reimbursement.

Eligibility & Benefits Verification

We confirm coverage, deductibles, co-pays, and in/out-of-network status before every oncology encounter — including specialty drug benefit verification for chemotherapy, biologics, and infusion services at each payer.

Prior Authorization Management

Our team manages the full PA lifecycle for chemotherapy regimens, immunotherapy, targeted therapies, device implantations, radiation treatments, and REMS-required drugs — from clinical documentation through payer submission and appeals.

Claims Submission & Tracking

We submit clean claims for all oncology services across office, infusion center, hospital, and radiation facility settings — monitoring each claim through its complete lifecycle and catching drug billing and modifier errors before rejection.

Denial Management & Appeals

Every denied oncology claim is reviewed, root-cause analyzed, and appealed with drug administration documentation, infusion hierarchy justification, wastage records, and medical necessity support to maximize recovery.

Accounts Receivable Follow-Up

Our AR specialists proactively pursue outstanding balances for chemotherapy drug claims, radiation therapy services, and high-value interventional oncology charges — keeping days in AR below specialty benchmarks.

Patient Statements & Collections

We manage the complete patient billing experience—from clear, understandable statements to respectful collection follow-ups—improving collections while preserving patient relationships.

Payment Posting & Reconciliation

All insurance and patient payments are posted and reconciled daily against expected reimbursements for drug, infusion, and radiation services — with systematic identification of drug billing underpayments for immediate appeal.

Provider Credentialing

We manage enrollment and credentialing with all commercial, Medicare, and Medicaid payers — including oncology drug program participation and specialty pharmacy partnerships — preventing credentialing-related claim delays.

Reporting & Analytics Dashboard

You receive real-time RCM dashboards covering collections by treatment modality, drug billing performance, wastage capture rates, denial patterns by CPT category, authorization status, and payer-specific oncology revenue trends.

Specialty-Specific RCM services

Chemotherapy Administration Billing (96401–96549)

Chemotherapy infusion billing requires precise sequencing of the initial infusion code (96413), additional hour add-ons (96415), push injection codes (96409), and concurrent drug infusion codes (96417) — with each sequence reflecting the actual order of drug administration documented in the infusion record. We code every chemotherapy encounter from the infusion flowsheet, ensuring all drugs and administration routes generate separate, compliant reimbursement.

Buy-and-Bill Drug Billing & Wastage Documentation

Buy-and-bill drug billing requires inventory tracking, J-code assignment, unit calculation per administered dose versus vial size, ASP pricing compliance, and documentation of unused portions with JW or JZ modifiers. We audit every single-dose vial encounter to identify missed wastage billing, adding incremental drug cost recovery to every infusion visit and protecting full pharmaceutical reimbursement.

Radiation Therapy Billing (77xxx Series)

Radiation therapy billing encompasses treatment planning (77261–77263), simulation (77295), dosimetry (77300–77316), and treatment delivery (77402–77432) — a multi-step billing process requiring coordination between the radiation oncologist and radiation physicist. We manage the complete radiation therapy billing cycle, ensuring every planning and delivery component generates appropriate reimbursement.

Immunotherapy & Biologic Drug Billing

Immunotherapy drugs — including checkpoint inhibitors (pembrolizumab, nivolumab, atezolizumab) and immunomodulators — require payer-specific prior authorization, J-code billing, and buy-and-bill drug cost recovery managed with ASP precision. We manage oncology biologic billing with pre-infusion PA verification and accurate J-code unit billing that ensures full drug cost recovery on every biologic encounter.

Oncology E&M with Complex MDM (99205, 99215)

Oncology E&M visits involve highly complex medical decision-making — managing active cancer treatment, interpreting tumor markers, and adjusting multi-drug regimens — that consistently supports the highest E&M levels under 2021 AMA guidelines. We ensure oncology E&M billing reflects the true complexity of cancer management, recovering the higher E&M reimbursement that every oncology visit supports.

Supportive Care & Port Access Billing

Supportive oncology services — antiemetic infusions, growth factor injections, blood transfusions, palliative care consultation, and port-a-cath access (96523) — each generate separate billable services alongside primary treatment. We identify and bill all supportive care services associated with each oncology encounter, capturing the complete per-visit revenue from complex cancer treatment sessions.

Clinical Trial & Protocol Billing

Clinical trial billing requires careful segregation of routine care costs (billable to insurance) from trial-related costs (covered by the sponsor), with payer-specific policies adding documentation complexity. We implement clinical trial billing segregation protocols ensuring insurance is billed correctly for routine care while trial sponsor obligations are correctly attributed on every research encounter.

OCM & Care Coordination Billing

Oncology Care Model participation requires billing Enhanced Oncology Services, tracking care coordination time, documenting patient navigation services, and meeting quality reporting standards. We manage OCM billing compliance to ensure all care coordination services generate appropriate reimbursement and that your practice remains in good standing under value-based oncology payment models.

ICD-10 Oncology Coding (C18.x, C34.x, C50.x, C61 Series)

Oncology ICD-10 coding requires precise identification of the primary malignancy site, histology, and laterality along with secondary malignancy codes for metastatic disease — with accurate staging and metastasis coding directly affecting treatment authorization and reimbursement. Our certified oncology coders ensure every claim reflects the complete staging and metastatic status of each patient’s malignancy.

Oncology RCM modules

AnnexMed’s ImpactRCM.AI platform delivers purpose-built intelligence modules for the drug-driven, multi-layer, high-compliance billing workflows that define oncology revenue cycle management. These modules operate across the full revenue cycle — identifying missed drug charges, preventing infusion coding errors before submission, and systematically recovering revenue that generic RCM systems cannot detect in complex oncology billing environments.
MODULE 01

Drug Billing Accuracy Engine

AI-driven validation scans every oncology drug encounter for J-code completeness, unit calculation accuracy against administered dose, ASP pricing compliance, and wastage documentation — ensuring no billable drug component is missed and every buy-and-bill encounter generates full pharmaceutical cost recovery.

MODULE 02

Infusion Hierarchy Validator

Automatically sequences chemotherapy administration codes by comparing encounter data against infusion flowsheet documentation — validating initial, concurrent, and sequential infusion code order to prevent bundling denials and ensure correct hierarchical billing on every multi-drug chemotherapy encounter.

MODULE 03

Prior Authorization Workflow Manager

Tracks authorization requirements and expiration dates for all oncology treatments — chemotherapy regimens, immunotherapy, targeted therapies, REMS-required biologics, and radiation procedures — with automated alerts before authorization lapses create denial risk or delay high-value cancer treatment delivery.

MODULE 04

Radiation Therapy Component Tracker

Manages TC/26 split billing across simulation, planning, dosimetry, and treatment delivery by tracking equipment ownership and interpreting physician documentation — ensuring every radiation therapy course generates correct two-party reimbursement with no component missed across the full treatment schedule.

MODULE 05

Wastage Recovery Auditor

Systematically audits every single-dose vial encounter to identify missed JW/JZ wastage billing, validates documentation precision against payer audit standards, and generates recovery actions for prior periods where wastage was not billed — adding incremental per-visit drug cost recovery across the infusion program.

MODULE 06

Denial Intelligence Dashboard

Real-time analytics tracking denial patterns by drug category, CPT code, modifier, payer, and documentation deficiency — enabling proactive denial prevention across oncology’s multiple billing layers, targeted coder education on high-failure codes, and payer-specific appeal strategy optimization.

Oncology billing quick reference

Procedure Category
Key CPT Codes
Billing Complexity
Common Denial Risk
Chemotherapy Administration

96413, 96415, 96409, 96417, 96401–96549

Very High

Incorrect infusion hierarchy; sequential vs. concurrent mismatch; missing add-on hour codes

Buy-and-Bill Drug Billing

J-codes (J9000 series), JW/JZ modifier

Very High

Incorrect unit calculation; missed wastage billing; ASP pricing error; NDC not reported

Radiation Therapy

77261–77263, 77295, 77300–77316, 77402–77432

Very High

TC/26 split error; dosimetry codes omitted; planning vs. delivery code mismatch

Immunotherapy / Biologics

J9271, J9299, J0129 (biologic J-codes)

Very High

PA not obtained before infusion; J-code unit error; buy-and-bill cost underclaimed

Oncology E&M

99202–99215 + modifier 25

High

Separately identifiable E&M not documented; modifier 25 denied on chemo day

Supportive Care / Port Access

96523, G-CSF codes, antiemetic codes

High

Port access bundled into infusion; growth factor codes omitted; antiemetic infusion not billed

Clinical Trial Billing

Routine care CPTs + trial documentation

Very High

Routine vs. trial cost misattribution; sponsor obligation billed to insurance; IRB compliance gap

OCM / Care Coordination

G0602, G0603, enhanced services codes

Medium

Care coordination time not tracked; navigation services undocumented; quality metric gap

ICD-10 Oncology Staging

C18.x, C34.x, C50.x, C61 malignancy series

High

Primary vs. secondary malignancy confusion; laterality not specified; staging code absent

Outcomes when you partner with AnnexMed

When you partner with AnnexMed for oncology RCM, you can expect measurable, sustained financial improvement driven by drug billing precision, infusion hierarchy accuracy, denial prevention across all CPT and HCPCS categories, and systematic revenue recovery across every stage of cancer treatment.

25–35%

Increase in Collections

96%+

Clean Claim Rate

30–40%

A/R Days Reduction

82–90%

Denial Overturn Rate

92%+

Diagnostic Capture Rate

100%

Billing Overhead Eliminated

What Sets AnnexMed Apart?

Oncology-Specific Expertise

Our dedicated oncology billing teams are trained exclusively in chemotherapy administration coding, buy-and-bill drug billing, radiation therapy, and the compliance requirements of cancer care reimbursement — with deep understanding of the multi-layer complexity that defines this specialty.

Buy-and-Bill Mastery

We expertly manage drug inventory tracking, J-code billing precision, unit calculation per administered dose, wastage documentation with JW/JZ modifiers, and specialty pharmacy coordination — capturing the full drug cost recovery value of every oncology encounter.

Proven Financial Results

We consistently achieve 96%+ clean claim rates and increase oncology practice revenue by an average of 25–35% through precise drug billing, systematic infusion coding, and aggressive denial management across all oncology service categories.

Infusion Hierarchy Mastery

Our coders sequence every chemotherapy encounter from the infusion flowsheet, correctly applying initial, concurrent, and sequential infusion codes to capture the complete per-visit drug administration revenue — eliminating the sequencing errors that are the leading source of oncology infusion revenue leakage.

Scalable Solutions

Whether you are a solo oncologist, a multi-physician oncology group, a hospital-based cancer program, or an academic medical center oncology department, we customize our RCM services to your treatment volume, drug formulary, payer mix, clinical settings, and billing complexity.

Compliance First

We maintain strict HIPAA compliance, stay current on CMS ASP pricing quarterly updates, HCPCS code changes, OCM policy revisions, and clinical trial billing regulations — while undergoing regular security audits to protect your practice from drug billing audit exposure and regulatory risk.

user-bg

Ready to optimize your oncology practice revenue?

Discover how much chemotherapy, drug billing, and radiation therapy revenue you may be leaving on the table and get a customized improvement plan from our oncology billing experts.

Frequently Asked Questions

Most oncology practices are fully operational within 3-4 weeks. We handle credentialing verification, system integration, drug billing setup, and historical data transfer with minimal disruption.
We integrate with all major oncology practice management and EMR systems. Our team has extensive experience with Flatiron, iKnowMed, OncoEMR, Epic Beacon, and other oncology-specific platforms.
Yes, buy-and-bill management is a core service. We track drug inventory, ensure proper J-code billing, calculate units accurately, document wastage, and manage specialty pharmacy coordination.
Our team monitors quarterly ASP updates from CMS, tracks HCPCS code additions, participates in oncology billing webinars, and maintains relationships with specialty pharmacies and drug manufacturers.
We maintain an 82-90% overturn rate on appealed oncology claims through proper drug administration documentation, medical necessity justification, and payer-specific appeal strategies.
Absolutely. We'll conduct an A/R audit focusing on high-value chemotherapy claims and radiation oncology services, identify collectible balances, develop a recovery strategy, and work outstanding claims while starting fresh.
Yes, prior authorization is a core service. We submit PA requests for chemotherapy regimens, immunotherapy, targeted therapies, CAR-T, and radiation treatments with comprehensive clinical documentation.
You'll have 24/7 access to our secure portal with real-time dashboards showing claims status, payments, denials, drug administration metrics, authorization tracking, wastage capture, A/R aging, and detailed financial analytics.
We support practices in OCM and other oncology value-based payment programs including enhanced services tracking, care coordination documentation, and quality measure reporting.
Yes, we have comprehensive expertise across all oncology services including medical oncology infusions, radiation therapy (simulation, planning, delivery), surgical oncology, and gynecologic oncology procedures.

Case Studies

See the impact we deliver

Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.

Client Voices

See how our clients succeed

Hear from organizations that trust AnnexMed to reduce denials, accelerate reimbursements, and strengthen cash flow. Our expert support delivers measurable performance gains, operational efficiency, financial stability, and scalable growth.
We had been missing wastage billing on single-dose vials for years. AnnexMed audited three months of drug encounters and identified the gap immediately. Our pharmaceutical cost recovery improved substantially in the first quarter.
Anx Image

Dr. Raymond Okafor

Medical Oncologist & Practice Owner
Our chemotherapy authorization denials were delaying patient treatment. AnnexMed restructured our prior authorization workflows and reduced our average approval time from three weeks to five days. Our infusion center utilization improved noticeably.
Anx Testimonial

Angela Torres

Cancer Treatment Center
Our radiation therapy TC/26 splits were billed incorrectly across two payers. AnnexMed identified the systematic error in the first audit cycle, corrected the billing configuration, and recovered the prior underpayments through appeals.
Anx Testimonial

Dr. Priya Nambiar

Regional Cancer Center

Proven RCM expertise. Delivered at scale.

For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.

Certification

Want to talk to our RCM experts?

    Oncology RCM That Understands the Complexity of Cancer Care

    In oncology medical billing, every claim tells the story of a complex care journey. It’s not just about CPT or HCPCS codes, it’s about documenting drug administration, managing prior authorizations, billing wastage, and aligning with strict payer rules. AnnexMed’s oncology medical billing services cover intake to collections: eligibility verification, prior authorization, coding, claims submission, denial management, and AR follow-up. Whether you are an independent oncology practice or a hospital-based cancer center, we tailor workflows to your specific needs.

    Oncology Billing Challenges That Drain Revenue

    Oncology billing is among the most complex in healthcare. High-cost drugs, multi-hour infusions, and strict compliance rules mean even small mistakes create large financial losses.

    Prior authorization breakdowns

    Expensive oncology drugs administered without pre-approval lead to automatic denials.

    Incorrect infusion coding

    Errors in oncology billing codes for initial vs. sequential vs. concurrent chemotherapy sessions cause underpayments.

    Drug wastage not reported

    Unused vials not billed with modifier JW or JZ result in lost reimbursement opportunities.

    Clinical trial billing errors

    Misalignment of research vs. routine care charges creates compliance and audit risks.

    Non-compliance with oncology billing guidelines

    Overlooking time-based infusion documentation, drug units, or NCCI edits stalls payments.

    Eligibility verification gaps

    Patients not pre-checked for oncology benefits face claim denials and delayed treatment reimbursement.

    Why Oncology Practices Choose AnnexMed?

    As one of the leading oncology billing companies, AnnexMed delivers unmatched accuracy, compliance, and revenue protection for cancer care providers.

    Don’t let coding errors dilute your claims, secure your oncology revenue today

    Our Oncology Medical Billing Services

    Oncology billing services demand precision at every step, drug units, infusion coding, prior authorizations, and payer-specific guidelines. AnnexMed delivers end-to-end support so oncologists can focus on patients while we protect their revenue.

    Infusion & Drug Administration Coding

    We manage initial, sequential, and concurrent infusion coding (96413, 96415, 96417) with accurate drug units and modifier usage.

    Prior Authorization for Oncology Treatments

    Securing approvals for chemotherapy, immunotherapy, and supportive drugs before administration to avoid high-value denials.

    Claims Submission & Eligibility Verification

    Submitting claims under oncology billing guidelines, with upfront benefit verification and payer-specific coverage checks.

    Oncology Billing Compliance & NCCI Edits

    We ensure claims adhere to oncology billing guidelines, including infusion time documentation, drug units per HCPCS, and NCCI bundling rules.

    Accounts Receivable Follow-Up

    Our AR team aggressively pursues unpaid claims, resolving denials linked to medical necessity, drug units, wastage modifiers, infusion coding, and eligibility mismatches.

    Clinical Trial & Supportive Care Billing

    Managing research vs. routine care separation, while capturing supportive treatments like antiemetics and growth factors correctly.

    Adhering to Industry Standards

    Delivering Oncology Billing With Compliance at Its Core

    Compliance in oncology medical billing services goes beyond checking for errors, it safeguards every claim against payer scrutiny, denials, and audit risk. AnnexMed integrates oncology billing guidelines into each stage of the revenue cycle, ensuring accuracy and accountability.

    We back this with system-led audit trails, payer-specific policy enforcement, and quarterly compliance drills. From intake to collections, every oncology claim is protected by layered controls, real-time alerts, and ongoing staff training. This approach minimizes risk, prevents denials, and keeps your practice audit-ready at all times.

    Annexmed SOC Certification

    SOC 2 Type 1

    Reporting on controls at a service organization
    ISO Certificate

    ISO 27001:2022

    Securing and protecting information
    Annexmed ISO Certification

    ISO 9001:2015

    Achieving quality policy and quality objectives
    Annexmed SOC Certification

    SOC 2 Type 2

    Implemented the SOC 2 approved by AICPA

    Case Studies

    How Healthcare Teams Are Winning with AnnexMed

    Turning Around Aged AR in 90 Days: A Multi-Specialty Case Study

    0 %
    Clean Claim Rate
    %
    Less Claim Rework
    0 %
    Appeal Success Rate
    Featured Blog

    Common Mistakes in Oncology Medical Billing and How to Avoid Them

    Protect Every Dollar Behind Every Dose.

    With AnnexMed’s oncology billing services, your life-saving treatments never go unpaid.

    Annexmed-logo
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.